FindTrial
Sign In

Kidney involvement in plasma cell disorders

Clinical profile of plasma cell dyscrasias and their renal outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/029098
Enrollment
100
Registered
2020-11-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C900- Multiple myeloma

Interventions

None listed

Sponsors

Kasturba medical college and Kasturba hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with plasma cell dyscrasias

Exclusion criteria

Exclusion criteria: Patients less than 18 years age

Design outcomes

Primary

MeasureTime frame
To study renal outcomes in patients with plasma cell dyscrasias and requirement of renal replacement therapyTimepoint: 18 months—

Secondary

MeasureTime frame
To study flow cytometry patterns in patients with plasma cell dyscrasiasTimepoint: 18 months—

Countries

India

Contacts

Public ContactNiharika Mulpuri

Kasturba medical college, Manipal

ravindra.prabhu@manipal.edu9177757383

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026